Literature DB >> 19691431

Laboratory diagnosis of infections due to blood and tissue parasites.

Jon E Rosenblatt1.   

Abstract

Microscopy remains the cornerstone of the laboratory diagnosis of infections due to blood and tissue parasites. Examination of thick and thin peripheral blood smears stained with Giemsa or other appropriate stains is used for detection and identification of species of Plasmodium, Babesia, Trypanosoma, Brugia, Mansonella, and Wuchereria. Even in the hands of well-trained technologists, diagnosis may be hampered by the sparseness of organisms on the slide and by the subjective nature of differentiating similar-appearing organisms. Microscopy and/or culture of ulcer, bone marrow, tissue aspirate, and biopsy samples are useful for the diagnosis of African trypanosomiasis, onchocerciasis, trichinosis, and leishmaniasis. Serologic assays are available for the diagnosis of a number of these infections, but none of these assays are sensitive or specific enough to be used on their own to establish a diagnosis. In particular, the use of assays for the diagnosis of infection with a particular helminth will often cross-react with antibodies to a different helminth. Very sensitive polymerase chain reaction assays have been developed for a number of these parasites and are available from the Centers for Disease Control and Prevention and from several referral laboratories.

Entities:  

Mesh:

Year:  2009        PMID: 19691431     DOI: 10.1086/605574

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Atypical Mansonella ozzardi Microfilariae from an Endemic Area of Brazilian Amazonia.

Authors:  Thuy-Huong Ta-Tang; Sergio L B Luz; Francisco J Merino; Isabel de Fuentes; Rogelio López-Vélez; Tatiana A P Almeida; Marta Lanza; Cláudia M M Abrahim; José M Rubio
Journal:  Am J Trop Med Hyg       Date:  2016-07-11       Impact factor: 2.345

Review 2.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

3.  Relevance of the eosinophil blood count in bancroftian filariasis as a screening tool for the treatment.

Authors:  Didier Musso
Journal:  Pathog Glob Health       Date:  2013-03       Impact factor: 2.894

4.  Filarial pleural effusion.

Authors:  K Gowrinath
Journal:  Ann Thorac Med       Date:  2011-01       Impact factor: 2.219

5.  Babesiosis in immunocompetent patients, Europe.

Authors:  Martin Martinot; Mahsa Mohseni Zadeh; Yves Hansmann; Isabelle Grawey; Daniel Christmann; Sarah Aguillon; Maggy Jouglin; Alain Chauvin; Dominique De Briel
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

6.  An Extremely Rare Situation - Subcutaneously Filariasis Presented at ED Craiova.

Authors:  Luciana Rotaru; C Șerban
Journal:  Curr Health Sci J       Date:  2014-03-29

Review 7.  The Utility of Blood and Bone Marrow Films and Trephine Biopsy Sections in the Diagnosis of Parasitic Infections.

Authors:  Clare E Miller; Barbara J Bain
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-06-01       Impact factor: 2.576

8.  Assessment of Clinical Diagnosis, Microscopy, Rapid Diagnostic Tests, and Polymerase Chain Reaction in the Diagnosis of Plasmodium falciparum in Nigeria.

Authors:  Olusola Ojurongbe; Olunike Olayeni Adegbosin; Sunday Samuel Taiwo; Oyebode Armstrong Terry Alli; Olugbenga Adekunle Olowe; Taiwo Adetola Ojurongbe; Oloyede Samuel Bolaji; Oluwaseyi Adegboyega Adeyeba
Journal:  Malar Res Treat       Date:  2013-11-24

Review 9.  Natural history of Zoonotic Babesia: Role of wildlife reservoirs.

Authors:  Michael J Yabsley; Barbara C Shock
Journal:  Int J Parasitol Parasites Wildl       Date:  2012-11-22       Impact factor: 2.674

Review 10.  New Molecules in Babesia gibsoni and their application for diagnosis, vaccine development, and drug discovery.

Authors:  Youn-Kyoung Goo; Xuenan Xuan
Journal:  Korean J Parasitol       Date:  2014-08-29       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.